NASDAQ:DSGN

Design Therapeutics Stock Insider Trading

etoro logo Buy DSGN
*Your capital is at risk
$10.44
+0.270 (+2.65%)
At Close: Jun 03, 2026

Design Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -25.71. In total, the insiders bought 18.55M and sold 2.76M DSGN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-25.71
Buy 18.55M shares
Sell 2.76M shares
92% Buy Activity
Negligible or No Correlation
Buy Signal Low Confidence
Jan 02, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -25.71.
  • Confidence increased due to high data reliability score of 100.
  • Supported by overwhelming buy-side pressure (92% buys).

Historical Insider Trades

Date Type Person Role Amount
Mar 31, 2026
Buy
Common Stock
J-Other
Shapiro David
Insider
Other 0
Value: $0
Mar 31, 2026
Buy
Stock option (right to buy)
A-Award
Shapiro David
Director
Director 7 500
Value: $79.8K
Mar 31, 2026
Buy
Stock option (right to buy)
A-Award
Shapiro David
Director
Director 60 000
Value: $638.4K
Jan 02, 2026
Buy
Stock option (right to buy)
A-Award
Shah Pratik
President, CEO And Chairperson
CEO / President 750 000
Value: $6.83M
Jan 02, 2026
Buy
Stock option (right to buy)
A-Award
Gover Justin D.
Director
Director 45 000
Value: $409.5K
Jan 02, 2026
Buy
Stock option (right to buy)
A-Award
Burgess Julie
Chief Accounting Officer
Officer 150 000
Value: $1.37M
Jan 02, 2026
Buy
Stock option (right to buy)
A-Award
Jeffries Sean
Chief Operating Officer
C-Suite Officer 375 000
Value: $3.41M
Jan 02, 2026
Buy
Stock option (right to buy)
A-Award
Storgard Chris
Chief Medical Officer
Officer 250 000
Value: $2.28M
Dec 09, 2025
Buy
Stock option (right to buy)
A-Award
Shah Pratik
President, CEO And Chairperson
CEO / President 525 000
Value: $1.30M
Sep 09, 2025
Buy
Stock option (right to buy)
A-Award
Gover Justin D.
Director
Director 30 000
Value: $199.2K
Sep 09, 2025
Buy
Stock option (right to buy)
A-Award
Gover Justin D.
Director
Director 15 833
Value: $105.1K
Sep 09, 2025
Buy
Common Stock
J-Other
Gover Justin D.
Insider
Other 0
Value: $0
Sep 09, 2025
Buy
Common Stock
J-Other
Gover Justin D.
Insider
Other 0
Value: $0
Sep 09, 2025
Buy
Stock option (right to buy)
A-Award
Gover Justin D.
Director
Director 15 833
Value: $105.1K
Sep 09, 2025
Buy
Stock option (right to buy)
A-Award
Gover Justin D.
Director
Director 30 000
Value: $199.2K
Aug 13, 2025
Sell
Common Stock
S-Sale
William Arsani
Director
Director 345 000
Value: $1.81M
Aug 13, 2025
Sell
Common Stock
S-Sale
William Arsani
Director
Director 217 627
Value: $1.14M
Aug 13, 2025
Sell
Common Stock
S-Sale
William Arsani
Director
Director 217 627
Value: $1.14M
Aug 13, 2025
Sell
Common Stock
S-Sale
William Arsani
Director
Director 345 000
Value: $1.81M
Jun 10, 2025
Buy
Stock Option (right to buy)
A-Award
George Simeon
Director 19 000
Value: $76.2K
Jun 10, 2025
Buy
Stock Option (right to buy)
A-Award
Prasad Deepa
Director
Director 19 000
Value: $76.2K
Jun 10, 2025
Buy
Stock Option (right to buy)
A-Award
William Arsani
Director
Director 19 000
Value: $76.2K
Jun 10, 2025
Buy
Stock Option (right to buy)
A-Award
Berger Heather A.
Director
Director 19 000
Value: $76.2K
Jun 10, 2025
Buy
Stock Option (right to buy)
A-Award
Schmid John P.
Director
Director 19 000
Value: $76.2K
Jun 10, 2025
Buy
Stock Option (right to buy)
A-Award
Lappe Rodney W
Director
Director 19 000
Value: $76.2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT DESIGN THERAPEUTICS, INC.
Design Therapeutics
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function, eventually leading to neurological, cardiac, and metabolic dysf...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE